“…Due to melanoma's intrinsic resistance to radiation and chemotherapeutic drugs, PDT has been suggested as an alternative therapeutic modality, which involved light induced destruction of cells or target tissues through sensitization to light by various photosensitizing agents; hypericin (Hadjur, Richard et al 1996), benzoporphyrin derivatives (Busetti, Soncin et al 1999) or protophorphyrin IX (PPIX) being just a few examples (Kiesslich, Krammer et al 2006). However, several resistance mechanisms such as; optical interference (Hadjur, Richard et al 1996;Busetti, Soncin et al 1999), anti-oxidant defense mechanisms of melanin (Hadjur, Richard et al 1996;Davids, Kleemann et al 2009), cytoprotective response through induction of autophagy (Davids, Kleemann et al 2009), melanosomes protecting melanocytes and melanoma cells against harmful effects of toxic intermediates (Davids, Kleemann et al 2009) and lastly ABCG2 transporters acting as efflux pumps making cells capable of eliminating toxic amounts of porphyrins (Bebes, Nagy et al 2011) cause reduction in efficacy of PDT on melanoma cells.…”